Tag Archives: Biotechnology Industry

Does Biotech History Repeat?

IPO-windows-btn

According to Mark Twain, “History does not repeat itself, but it does rhyme”. Little did he know that one day that would hold true for something called “Biotech”. Indeed, there seems to be a lot of rhyming going on with Biotech IPOs today with recent history. When we compare the accumulated number of IPOs in the last IPO window (2003-2007) with the current window (2009-now), we see an amazing overlay. Not identical, but not too far from it. Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Programming Updates to the 2012 BIO International Convention

sarah-thumb

With Convention less than four months away, things are quickly falling in to place with several programming updates to note! A total of 115 breakout sessions have been confirmed and scheduled, including 18 international case studies.  Session organizers are currently finalizing speakers.  All session descriptions and confirmed speakers are available on myBIO. Even after all of the session submissions work, we asked for more session ideas! We recently completed a call for “Late-Breaking” sessions in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Industry Outlook in Anticipation of the 2012 BIO International Convention

HC5O7460

This month, BIO wrapped the 14th Annual CEO & Investor Conference in New York City at the Waldorf=Astoria. Hosted by BIO, the event drew more than 1,200 industry leaders, featured 140 company presentations and a record breaking 1,300+ one-on-one meetings between 225 companies. Taking the momentum from this meeting, we now look ahead to the 2012 BIO International Convention to be held June 18 – 21, 2012 at the Boston Convention & Exhibition Center in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Shoppers Already Have a Choice Regarding Biotech Foods

Greg Conko

Food Chemical News (an Agra Informa publication) ran a thorough editorial in its February 17 edition on the biotech food labeling debate. In this piece, Gregory Conko, a senior fellow at the Competitive Enterprise Institute, explains why it would be unnecessary to require special labeling for foods containing biotech ingredients: “Today, there are many thousands of affirmatively labeled, non-biotech foods available in stores as varied as Whole Foods Markets and Wal-Mart. “From just 2000 to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Oncology Clinical Trials – Secrets of Success

Graph

At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that drugs in development for oncology indications had the lowest overall clinical trial success rate of all therapeutic areas in development since 2004. We have updated these numbers to include clinical trials through December 2011. Although overall success rates did improve slightly, oncology remained in last place. The chart below illustrates why oncology’s overall success rate is so low relative to Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,